Nkarta (NKTX) Assets (2019 - 2026)
Nkarta (NKTX) posted quarterly Assets of $372.1 million for Q1 2026, down 20.94% year-over-year from $470.6 million in Q1 2025, and down 7.95% quarter-over-quarter from $404.2 million in Q4 2025.
Nkarta (NKTX) Assets (2019 - 2026) Analysis & Trends
Nkarta's Assets history runs 8 years deep, the most recent figure standing at $372.1 million for Q1 2026.
- In Q1 2026, Assets fell 20.94% year-over-year to $372.1 million; the TTM figure through Mar 2026 stood at $372.1 million (down 20.94% YoY), while the FY2025 annual figure was $404.2 million, down 19.35% from the prior year.
- Assets for Q1 2026 stood at $372.1 million, down from $404.2 million in the prior quarter.
- The five-year high for Assets was $576.9 million in Q1 2024, with the low at $306.3 million in Q1 2022.
- The 5-year median for Assets is $458.2 million (2023), against an average of $455.6 million.
- The sharpest annual moves came in 2022 and 2026: Assets jumped 72.67% in 2022, then slipped 20.94% in 2026.
- Nkarta's Assets stood at $472.9 million in 2022, then slipped by 19.89% to $378.9 million in 2023, then jumped by 32.28% to $501.2 million in 2024, then fell by 19.35% to $404.2 million in 2025, then decreased by 7.95% to $372.1 million in 2026.
- Business Quant data shows NKTX's Assets at $372.1 million in Q1 2026, $404.2 million in Q4 2025, and $427.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 19.82 Bn |
| 10 | Nkarta | 195.55 Mn | 195.55 Mn | - | 337.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 337.65 Mn |
| Mar 31, 2026 | 372.07 Mn |
| Dec 31, 2025 | 404.21 Mn |
| Sep 30, 2025 | 427.24 Mn |
| Jun 30, 2025 | 448.31 Mn |
| Mar 31, 2025 | 470.61 Mn |
| Dec 31, 2024 | 501.20 Mn |
| Sep 30, 2024 | 532.03 Mn |
| Jun 30, 2024 | 554.09 Mn |
| Mar 31, 2024 | 576.94 Mn |
| Dec 31, 2023 | 378.89 Mn |
| Sep 30, 2023 | 405.86 Mn |
| Jun 30, 2023 | 429.04 Mn |
| Mar 31, 2023 | 458.17 Mn |
| Dec 31, 2022 | 472.94 Mn |
| Sep 30, 2022 | 503.80 Mn |
| Jun 30, 2022 | 503.64 Mn |
| Mar 31, 2022 | 306.30 Mn |
| Dec 31, 2021 | 273.90 Mn |
| Sep 30, 2021 | 292.47 Mn |